Here is why Berkeley Lights is down 30%
Berkely Lights CEO is taking up a new role as the president of the Antibody Therapeutics department.
Stay updated with breaking news from Berkeley Lights. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Berkely Lights CEO is taking up a new role as the president of the Antibody Therapeutics department.
SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on...
/PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action...
/PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.